Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CD | SBET |
|---|---|---|
| Price | $10.15 | $8.95 |
| Change today | ▲ 22.00% | ▼ 5.79% |
| Market cap | $1.12B | $1.94B |
| Return, 3 months | +180.8% | +68.2% |
| Return, year to date | +104.2% | +0.1% |
| Return, 1 year | -66.4% | -49.1% |
| P/E (TTM) | 23.6 | -2.0 |
| P/B | 2.2 | 1.4 |
| P/E percentile vs own 5y | 100th | 11th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +98.4% | +1,553.9% |
| Net profit growth (YoY) | +28.5% | -281.2% |
| Gross margin | 59.8% | 97.0% |
| Operating margin | -169.4% | -18.4% |
| Net margin | -182.5% | -3,406.3% |
| Return on equity | -12.4% | -183.6% |
| Analyst target vs. price | – | +97.4% |
| Analyst buy share | – | 100% |
| RSI (14) | 85 | 50 |
| 30-day volatility | 157.4% | 80.6% |
| Max drawdown, 1 year | -92.6% | -76.3% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
